|
Up a level |
Arab-Alameddine, M; Lubomirov, R; Fayet-Mello, A; Aouri, M; Rotger, M; Buclin, T; Widmer, N; Gatri, M; Ledergerber, B; Rentsch, K; Cavassini, M; Panchaud, A; Guidi, M; Telenti, A; Décosterd, L A; Csajka, C (2014). Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals. Journal of Antimicrobial Chemotherapy, 69(9):2489-2498.
Lubomirov, R; di Iulio, J; Fayet, A; Colombo, S; Martinez, R; Marzolini, C; Furrer, H; Vernazza, P; Calmy, A; Cavassini, M; Ledergerber, B; Rentsch, K; Descombes, P; Buclin, Thierry; Decosterd, L A; Csajka, C; Telenti, A (2010). ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir. Pharmacogenetics and Genomics, 20(4):217-230.
di Iulio, J; Fayet, A; Arab-Alameddine, M; Rotger, M; Lubomirov, R; Cavassini, M; Furrer, H; Günthard, H F; Colombo, S; Csajka, C; Eap, C B; Decosterd, L A; Telenti, A (2009). In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function. Pharmacogenetics and Genomics, 19(4):300-309.